Pharma Bio Serv Stock Today
| PBSV Stock | USD 0.50 0.05 9.09% |
Performance0 of 100
| Odds Of DistressLess than 10
|
Pharma Bio is selling for under 0.5 as of the 11th of December 2024; that is 9.09 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.5. Pharma Bio has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 19th of August 2023 and ending today, the 11th of December 2024. Click here to learn more.
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico. Pharma Bio operates under Health Information Services classification in the United States and is traded on OTC Exchange. The company has 22.95 M outstanding shares. More on Pharma Bio Serv
Moving together with Pharma OTC Stock
| 0.81 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.76 | PPERF | Bank Mandiri Persero | PairCorr |
| 0.65 | BKRKF | PT Bank Rakyat | PairCorr |
| 0.78 | BKRKY | Bank Rakyat | PairCorr |
| 0.73 | PBCRY | Bank Central Asia | PairCorr |
Moving against Pharma OTC Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Pharma OTC Stock Highlights
| CEO | Victor Sanchez |
| Business Concentration | Health Care, Life Sciences Tools & Services, Health Information Services, Healthcare (View all Sectors) |
Pharma Bio Serv [PBSV] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with a current market capitalization of 20.88 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pharma Bio's market, we take the total number of its shares issued and multiply it by Pharma Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Pharma Bio Serv conducts business under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 22.95 M outstanding shares.
Pharma Bio Serv currently holds about 14.24 M in cash with 592.46 K of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.62, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Pharma Bio Probability Of Bankruptcy
Ownership AllocationPharma Bio owns a total of 22.95 Million outstanding shares. Pharma Bio holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 64.53 pct. of Pharma Bio Serv outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Pharma Ownership Details
Pharma Bio Serv Risk Profiles
| Mean Deviation | 3.06 | |||
| Standard Deviation | 6.01 | |||
| Variance | 36.16 | |||
| Risk Adjusted Performance | (0.02) |
Pharma Stock Against Markets
Picking the right benchmark for Pharma Bio otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Pharma Bio otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Pharma Bio is critical whether you are bullish or bearish towards Pharma Bio Serv at a given time. Please also check how Pharma Bio's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Pharma Bio without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Share Portfolio Now
Share PortfolioTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Pharma Bio Corporate Executives
Elected by the shareholders, the Pharma Bio's board of directors comprises two types of representatives: Pharma Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pharma. The board's role is to monitor Pharma Bio's management team and ensure that shareholders' interests are well served. Pharma Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pharma Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pedro Lasanta | CFO, VP of Fin. and Admin. and Secretary | Profile |
Additional Tools for Pharma OTC Stock Analysis
When running Pharma Bio's price analysis, check to measure Pharma Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma Bio is operating at the current time. Most of Pharma Bio's value examination focuses on studying past and present price action to predict the probability of Pharma Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma Bio's price. Additionally, you may evaluate how the addition of Pharma Bio to your portfolios can decrease your overall portfolio volatility.